0.5024 USD
-0.0582
10.38%
At close Jan 17, 4:00 PM EST
After hours
0.4999
-0.0025
0.50%
1 day
-10.38%
5 days
-4.03%
1 month
14.44%
3 months
16.84%
6 months
-22.11%
Year to date
21.35%
1 year
-32.47%
5 years
-99.04%
10 years
-99.80%
 

About: cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Employees: 42

0
Funds holding %
of 6,823 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

47% more capital invested

Capital invested by funds: $50.2K [Q2] → $73.5K (+$23.3K) [Q3]

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

1.74% more ownership

Funds ownership: 2.21% [Q2] → 3.96% (+1.74%) [Q3]

0% more funds holding

Funds holding: 19 [Q2] → 19 (+0) [Q3]

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Research analyst outlook

We haven’t received any recent analyst ratings for YCBD.

Financial journalist opinion

Based on 4 articles about YCBD published over the past 30 days

Neutral
Newsfile Corp
5 days ago
cbdMD Announces It Has Fully Satisfied Its Notes
Charlotte, North Carolina--(Newsfile Corp. - January 15, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has fully satisfied the accrued interest and principal associated with its Senior Secured Convertible Notes. As of January 14, 2025, there are 6,262,833 shares of the Company's common stock issued and outstanding.
cbdMD Announces It Has Fully Satisfied Its Notes
Neutral
Newsfile Corp
1 week ago
cbdMD Announces Additional Conversions of Its Convertible Notes
Charlotte, North Carolina--(Newsfile Corp. - January 8, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that the Company has reduced the principal amount outstanding on its Senior Secured Convertible Notes to approximately $56,000 as of January 8, 2025 as certain holders of the notes have converted amounts under the notes. Since the start of the year, the Company has issued an aggregate of 609,717 shares of common stock as a result of conversion requests and the aggregate balances under the notes have been reduced by approximately $309,000 of principal in addition to accrued interest.
cbdMD Announces Additional Conversions of Its Convertible Notes
Neutral
Newsfile Corp
2 weeks ago
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
Charlotte, North Carolina--(Newsfile Corp. - January 3, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated December 31, 2024, notifying the Company that it is no longer in compliance with an additional NYSE American continued listing standard. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(i) of the NYSE American Company Guide (the "Company Guide").
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard
Neutral
Newsfile Corp
4 weeks ago
cbdMD Announces Company's CEO Joins the Board of Directors
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), a leading and highly trusted CBD company known for its flagship brands cbdMD and Paw CBD, as well as its innovative functional mushroom brand ATRx Labs, today announced that T. Ronan Kennedy, the Company's Chief Executive Officer and Chief Financial Officer, has been appointed to its Board of Directors.
cbdMD Announces Company's CEO Joins the Board of Directors
Neutral
Newsfile Corp
1 month ago
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
Finishes the year with a stronger cash position. Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced our financial results for the full fiscal year ended September 30, 2024.
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
Neutral
Newsfile Corp
1 month ago
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - December 18, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, December 18, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Neutral
Newsfile Corp
1 month ago
cbdMD, Inc. Reschedules Earnings Release and Conference Call
Charlotte, North Carolina--(Newsfile Corp. - December 17, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), today announced that it has postponed the release of its financial results and conference call related to the fourth quarter and fiscal year ended September 30, 2024, which had previously been scheduled for December 17, 2024. cbdMD currently expects to issue its fourth quarter and fiscal year 2024 financial results after market close on Wednesday, December 18, 2024.
cbdMD, Inc. Reschedules Earnings Release and Conference Call
Neutral
Newsfile Corp
1 month ago
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Charlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, December 17, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
Neutral
Newsfile Corp
2 months ago
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers
Charlotte, North Carolina--(Newsfile Corp. - November 14, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) a trusted leader in the wellness and cannabinoid industry, is excited to announce the launch of Herbal Oasis Social Tonics—a carefully crafted low-calorie, hemp derived THC seltzer line designed to elevate social occasions with a blend of premium cannabinoids and adaptogenic mushrooms. Available in four delicious flavors—Lemon Lift, Tropical Twist, Mango Bliss, and Berry Fusion—Herbal Oasis is designed to deliver an experience that enhances social connection and well-being, offering an alternative to traditional alcoholic drinks.
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers
Neutral
Newsfile Corp
4 months ago
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Charlotte, North Carolina--(Newsfile Corp. - August 26, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs, today announced that it received notice from the NYSE American LLC that it had accepted the Company's plan to regain compliance with the NYSE American continued listing standards and granted a plan period through December 5, 2025. As previously disclosed on June 5, 2024, the Company received a letter from the NYSE American stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(ii) of the NYSE American Company Guide.
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American
Charts implemented using Lightweight Charts™